In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...
Gajilan, who has worked at Reuters for more than 14 years and was then digital news director, had been reading about artificial intelligence and custom GPTs—tailored AI models that users could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback